Nicotinic Acid Market Outlook from 2025 to 2035

The global nicotinic acid market is estimated to be worth USD 362.4 million by the end of 2025 and is projected to reach a value of USD 601.7 million by 2035, growing at a CAGR of 5.2% over the assessment period 2025 to 2035.

The recognition of the health benefits of nicotinic acid, or niacin or vitamin B3 as it is also known, explains the increase in its sales. Nicotinic acid is required for skin, nerve, and digestive health as well as food metabolism and energy production.

As consumers are becoming more health conscious and taking a more proactive approach to their diet, there has been an increasing popularity of niacin in dietary supplements and fortified foods. The interest of the pharmaceutical sector in niacin has also enhanced its industry considerably.

There is a demand-supply gap. Niacin is in high demand for treating patients with pellagra, which is a clinical manifestation of a deficiency of vitamin B3. It is well known that a low level of niacin increases both bad (LDL) and triglycerides while a high level of niacin lowers good (HDL) levels of cholesterol.

Jubilant Life Sciences, an Indian pharmaceutical company, has been engaged in the manufacture of high-quality vitamin B3 targeting pharmaceutical and nutritional applications. Their constant focus on innovation and quality has helped them become a significant player in the industry.

Likewise, Lonza Group, a traditional Swiss multinational, has applied its advanced biotechnology resources to niacin production complying with pharmaceutical grades to suffice the global industry. Apart from its well-recognized anti-inflammatory properties, niacin has also been found to enhance skin elasticity and hydration. This has prompted its use in a range of skin care products, targeting consumers who are looking for reliable anti-aging products.

Attributes Description
Estimated Global Nicotinic Acid Industry Size (2025E) USD 362.4 million
Projected Global Nicotinic Acid Industry Value (2035F) USD 601.7 million
Value-based CAGR (2025 to 2035) 5.2%

To conclude, the rapid growth in sales of vitamin B3 can be attributed to the multi-benefits, its relevance in pharmaceutical and cosmetic usage, as well as the work of dominating companies such as Jubilant Life Sciences and Lonza Group who are working towards improving the quality of their products in line with increasing sales.

Exclusive Offer: 30% Off on Regional Reports

Get a free sample report and customize your regions for a 30% discount on your regional report!

Semi-Annual Market Update

The below table presents a comparative assessment of the variation in CAGR over six months for the base year (2024) and current year (2025) for the global nicotinic acid industry. This analysis reveals crucial shifts in performance and indicates revenue realization patterns, thus providing stakeholders with a better vision of the growth trajectory over the year. The first half of the year, or H1, spans from January to June. The second half, H2, includes the months from July to December.

Particular Value CAGR
H1 4.5% (2024 to 2034)
H2 4.7% (2024 to 2034)
H1 4.9% (2025 to 2035)
H2 5.2% (2025 to 2035)

In the first half (H1) of the decade from 2024 to 2034, the business is predicted to surge at a CAGR of 4.5%, followed by a higher growth rate of 4.7% in the second half (H2) of the same decade. Moving into the subsequent period, from H1 2025 to H2 2035, the CAGR is projected to increase to 4.9% in the first half and remain considerably high at 5.2% in the second half. In the first half (H1) the sector witnessed an increase of 30 BPS while in the second half (H2), the business witnessed a decrease of 15 BPS.

Key Industry Highlights

The Integration of Nicotinic Acid into Skincare and Cosmetic Products

There is a growing awareness and demand for skincare products that are natural and that contain active ingredients that address a variety of skin problems, including blemishes and wrinkles. Key companies such as BASF are leveraging this trend through developing focused niacin products. For example, BASF's Niacinamide is intended to help with skin texture, fine wrinkles pore dilation, and uneven tone.

The company’s research has proven that nicotinic acid improves skin barrier function, and collagen production and protects the skin from environmental factors. These claims provide substance to the science behind the benefits and thus lead to growth in the industry for niacin-based skincare and cosmetic products. Similarly, other leading manufacturers are also following this trend, for example, Lunza and Vertellus are producing vitamin B3 products with a focus on nutrition and sustainability.

Sustained-Release Nicotinic Acid Supplements Driving the Holistic Health Landscape

As lifestyle becomes busy, users are looking for sustained-release supplements to gain gradual nutrients. The trends reflect the need for improved health around the globe as well as ease of use. For example, companies such as Vertellus are spearheading cutting-edge formulations able to provide niacin in a phasic manner.

Products have been launched on the market to cater to such exceptional user compliance, thus enhancing needs. Likewise, Lonza Group is sponsored to undertake research that would assist in formulating novel sustained-release solutions.

As more users understand the benefits of niacin such as better heart health and lower cholesterol levels, they prefer using supplements that offer long-term effects without the need to use them frequently. This is a concern for many manufacturers and consequently, they are forced to develop new products and follow the changes that are taking place in the industry to remain competitive.

The Rise of Naturally-Sourced Vitamin B3 Supplements in the Organic Wellness Industry

A growing number of health-conscious consumers are turning towards organic and natural vitamin B3 supplements. This change is mostly accentuated by the increased consumer knowledge of the benefits of using natural ingredients as opposed to their synthetic counterparts.

This is the reason why companies like Jubilant Life Sciences are emphasizing the organic and natural aspects of their niacin products. For instance, Jubilant Life Sciences's marketing strategy has incorporated the use of natural ingredients in product formulations to attract specific clientele.

Likewise, DSM is focused on producing vitamin B3 supplements that are organically certified by the measures that the consumers want. Not only are the consumers' interests catered for, but this also promotes development in the industry as the manufacturers tend to come up with more efficient alternatives in a bid to meet the needs of a new generation of health-oriented consumers.

Get Brochure on Email

Almost 80% of our clients request uniquely tailored intelligence.

2020 to 2024 Global Nicotinic Acid Sales Analysis Compared to Demand Forecasts for 2025 to 2035

Global sales increased at a CAGR of 4.7% from 2020 to 2024. For the next ten years (2025 to 2035), projections are that expenditure on such products will rise at 5.2% CAGR.

The increasing medical awareness regarding Vitamin B3 has given a rise in the sales of the product, a trend that is expected to proliferate during the next decade. Between 2020 and 2024, the business ecosystem has been enjoying consistent growth accompanied by increasing recognition of the capabilities of this important nutrient.

The rise in the number of cardiovascular disorders and understanding of the role of nicotinic acid in controlling cholesterol levels is one of the main reasons for the sales growth. As more and more individuals become aware of heart diseases, the need for vitamin B3 supplements as well as Niacin-enriched food items has increased. This trend has been leveraged by major players like Lonza Group, BASF SE, and Vertellus Specialties by increasing their production capacity and launching new niacin-based products.

In the forecast period from the year 2025 to 2035, the industry is expected to grow larger. There is an increasing population of the elderly as well as an increase in the prevalence of metabolic diseases, which is likely to increase the demand for niacin as a drug. Further, the increased acceptance of clean and natural products has made the public seek out nicotinic acid which in turn increased sales. The supply side is now responding to this demand by trying to develop more effective and bioequivalent Nicotinic Acid through research and development.

Also, there has been an increased understanding of the importance of niacin and its use now extends from cardiovascular-related problems to cognitive function, skin, and even energy production. Such a variety of applications is expected to propel growth in the coming years and will be an attractive investment opportunity for both existing companies and new investors.

Market Concentration

The dominating firms in the industry include companies like DSM N.V., Lonza Group, and Jubilant Life Sciences. Such companies have strong networks because they have the resources necessary for expanding their product lines through heavy investment in research and development. Such businesses easily control the supply chain and spend large amounts of money on branding to ensure they control the market. Their goods are extensively employed in pharmaceutical products, health supplements, and cosmetics.

The tier 2 companies have a decent share of the industry. Some of these companies include Vertellus and Resonance Specialties Limited which tend to deal with certain segments of the industry. They usually focus on certain affordable production processes to meet specialized segments or certain regions.

These firms may not reach the same level of influence as some Tier 1 companies, but they are equally important in satisfying the demand for niacin in various industries, like animal feeds and food additives. Their responsiveness to changes in the industry allows them to remain competitive.

Tier 3 firms earn limited revenue and tackle restricted market size. These entities like Lasons India Pvt. Ltd. and TCI Chemicals are primarily operational in local or regional territories with a focus on segments. They rely on collaborations and partnerships to advance their presence in the industry. Even though they are smaller in size, Tier 3 companies increase the breadth of the market by introducing unique products and serving niche customers.

Check Free Sample Report & Save 40%!

Select your niche segments and personalize your insights for smart savings. Cut costs now!

Country-wise Insights

The following table shows the estimated growth rates of the top three territories. USA and China are set to exhibit high consumption, recording CAGRs of 4.3% and 5.1%, respectively, through 2035.

Countries CAGR 2025 to 2035
USA 4.3%
China 5.1%
India 6.2%
Germany 4.0%
Japan 5.6%

Rising Prevalence of Cardiovascular Diseases and Supplement-culture Boosting the USA Sales

The USA has become an important geography for the growth of the vitamin B3 industry owing to several reasons which have accelerated the growth in sales. One of the major reasons is the growing incidence of cardiovascular ailments which has made the American populace more aware of the advantages of using niacin for proper cholesterol balance.

Prominent firms, including Lonza Group and BASF SE, benefited from this phenomenon by increasing their production capabilities and launching new niacin formulations that met the needs of the American industry. Besides, the increasing trend of using clean-label and organic supplements among American consumers created demand for nicotinic acid as the major source of Vitamin B3, which in turn increased sales.

Companies such as Jubilant Life Sciences have been able to fill that gap by providing sustained-release formulations of vitamin B3 which is more continuous and smoother in supply of the nutrient.

The Dual Impact of Nicotinic Acid Shaping the Chinese Pharmaceutical and Cosmetic Industries

Apart from the pharmaceutical and nutraceutical industries, the niacin industry expansion has also been augmented by the Chinese space of cosmetics and skin care. The Chinese population has begun to understand more the usefulness of niacinamide in the preservation of skin, with the nutrients being added to various kinds of cosmetics.

Domestic companies like Lasons have also come up with novel niacin-containing formulations, which are based on the growing tastes of the Chinese population, thus further contributing to the growth of the vitamin B3 sector in the country.

Moreover, the efforts of the government of China to encourage the usage of traditional Chinese medicine and natural supplements have given a favorable legal climate for vitamin B3-containing products. This has compelled both foreign and local players to venture into the Chinese industry, thus increasing the growth of the niacin industry’s rapid growth.

Fortified Foods and Organic Skincare Products Leading to Sustained Growth in Indian Industry

The Indian industry is witnessing astonishing growth, and this is due to the booming industry of fortified foods and the expanding skincare industry in the country. Increased understanding of the vitamin's role in nutrition replenishment has seen its penetration into dietary supplements and functional foods.

At the same time, a growing trend focusing on natural products and organic substances fueled the demand for niacin-containing formulations. Prominent Indian players like Jubilant Life Sciences, have managed to take advantage of these trends by providing competitive vitamin B3 products to meet the needs of the local market.

With increasing health awareness among the Indian population and the never-ending development in the cosmetic industry, the industry for vitamin B3 is likely to grow consistently in the future, and this continues to strengthen its role as an essential substance within the Indian growing wellness and beauty field.

Category-Wise Insights

Liquid Form of Nicotinic Acid Acting as a Catalyst for Industry Expansion

Segment Liquid (By Form)
Value Share (2025) 25.5%

The liquid segment is also booming due to an increase in convenience and bioavailability of the formulations on various target markets. Companies such as BASF and DSM have identified this need and responded accordingly, by launching new liquid niacin products that cater to the needs of health-conscious people.

The liquid segment growth across the globe has also been aided by the expansion of the nutraceuticals industry, as well as the increased use of niacin in sports nutrition and energy beverages. Furthermore, the liquid form usage for targeted supplementation, especially to meet deficiencies, has gained traction amongst nutritionists and fitness trainers.

Major players are focusing on research and development to improve the bioavailability and effectiveness of their liquid products and meet the demands of consumers in various geographic regions.

Rising Consumption of Vitamin B3 Dietary Supplements Changing the Industry Dynamics

Segment Dietary Supplements (By End-use Industry)
Value Share (2025) 32.7%

Consumers are taking a more active role in their health and searching for supplements that will help them cope with conditions such as high cholesterol, and coronary disease among others. There is a very high requirement for which nicotinic acid is used, such as for its ability to reduce cholesterol levels. Companies such as Koninklijke DSM N.V. and Lonza Group are consistently on the cutting edge of the industry with their innovative formulations of vitamin B3 that address these health issues.

Also, the growing focus on preventive health care makes more consumers ready to use vitamin B3 supplements as part of daily life. The ease of use of dietary supplements and their beneficial effects on health are the major factors driving the growth of the industry. This rise in demand is also complemented by the extensive advertising campaigns as well as the education that the manufacturers do on the benefits of niacin to one’s general health and well-being.

Competition Outlook

Diverse organizations aim for innovation, so they have meaningful market presence, for example, DSM, Lonza, and Jubilant Life due to their scientific focus, have invested a lot in research and development. These kinds of companies are utilizing and investing in technologies that would improve niacin-based products due to the increased demand for health and wellness supplementation.

On the other hand, Vertellus and players such as Resonance Specialties Limited focus mainly on low-cost and regional targets. They use local distributors for better outreach and marketing. Companies like Lasons India Pvt. Ltd. And TCI Chemicals, however, are also competing in the Indian industry with agility and specialization. Consistently, such enterprises are actively engaged in strategic alliances and collaborations to improve their product scope and explore new potential areas.

Many manufacturers are now focusing on educating their customers through awareness drives aimed at explaining the uses of nicotinic acid leading to increased sales. This multi-dimensional strategy that includes advancement in technology, low production cost, and focused marketing has resulted in vigorous competition in the industry.

For instance

  • BASF introduced a new product from their skincare line which contains niacinamide and is meant for texture enhancement and anti-aging. This product was in line with the business objectives set by BASF to increase its market share in the cosmetic industry.
  • Jubilant Life Sciences announced the expansion of its nicotinic acid production facilities in India to meet the growing demand for dietary supplements and pharmaceutical applications.

Leading Brands

  • Graham Chemical
  • Glanbia plc
  • Lonza Group AG
  • Jubilant Life Sciences Ltd.
  • NutraScience Labs
  • DSM
  • BASF SE
  • Western Drugs Ltd.
  • Spectrum Chemical Mfg. Corp
  • Fengchen Group Co., Ltd
  • Others
Table of Content
  • 1. Executive Summary
  • 2. Industry Introduction, Including Taxonomy and Market Definition
  • 3. Market Trends and Success Factors, Including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
  • 4. Global Market Demand Analysis 2020 to 2024 and Forecast 2025 to 2035, including Historical Analysis and Future Projections
  • 5. Pricing Analysis
  • 6. Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035
    • 6.1. Form
    • 6.2. Grade
    • 6.3. Source
    • 6.4. End-use Industry
    • 6.5. Region
  • 7. Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, by Form
    • 7.1. Powder
    • 7.2. Liquid
    • 7.3. Tablets/Capsules
  • 8. Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, by Grade
    • 8.1. Feed Grade
    • 8.2. Food Grade
    • 8.3. Pharmaceutical Grade
  • 9. Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, by Source
    • 9.1. Natural
    • 9.2. Synthetic
  • 10. Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, by End-use Industry
    • 10.1. Dietary Supplements
    • 10.2. Functional Foods and Beverages
    • 10.3. Infant Food
    • 10.4. Animal Feed
    • 10.5. Personal Care
    • 10.6. Pharmaceuticals
    • 10.7. Others
  • 11. Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, by Region
    • 11.1. North America
    • 11.2. Latin America
    • 11.3. Western Europe
    • 11.4. Eastern Europe
    • 11.5. Balkans & Baltic
    • 11.6. Russia & Belarus
    • 11.7. Central Asia
    • 11.8. East Asia
    • 11.9. South Asia & Pacific
    • 11.10. Middle East & Africa
  • 12. North America Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
  • 13. Latin America Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
  • 14. Western Europe Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
  • 15. Eastern Europe Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
  • 16. Balkans & Baltic Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
  • 17. Russia & Belarus Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
  • 18. Central Asia Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
  • 19. East Asia Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
  • 20. South Asia & Pacific Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
  • 21. Middle East & Africa Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
  • 22. Sales Forecast 2025 to 2035 by Form, Grade, Source, and End-use Industry for 30 Countries
  • 23. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
  • 24. Company Profile
    • 24.1. Graham Chemical
    • 24.2. Glanbia plc
    • 24.3. Lonza Group AG
    • 24.4. Jubilant Life Sciences Ltd.
    • 24.5. NutraScience Labs
    • 24.6. DSM
    • 24.7. BASF SE
    • 24.8. Western Drugs Ltd.
    • 24.9. Spectrum Chemical Mfg. Corp
    • 24.10. Fengchen Group Co., Ltd
    • 24.11. Others

Key Segments of the Report

By Form:

As per form, the industry has been categorized into Powder, Liquid, and Tablets/Capsules.

By Grade:

This segment is further categorized into Feed Grade, Food Grade, and Pharmaceutical Grade.

By Source:

This segment is further categorized into Natural and Synthetic.

By End-use Industry:

This segment is further categorized into Dietary Supplements, Functional Foods and Beverages, Infant Food, Animal Feed, Personal Care, Pharmaceuticals, and Others.

By Region:

Industry analysis has been carried out in key countries of North America, Latin America, Western Europe, Eastern Europe, Balkans & Baltic, Russia & Belarus, Central Asia, East Asia, South Asia & Pacific, and the Middle East & Africa.

Frequently Asked Questions

What is the current value of the nicotinic acid industry?

The global industry is estimated at a value of USD 362.4 million in 2025.

At what rate did the sales of nicotinic acid grow between 2020 and 2024?

Sales increased at 4.7% CAGR between 2020 and 2024.

Who are the leading manufacturers of nicotinic acid?

Some of the leaders in this industry include Graham Chemical, Glanbia plc, Lonza Group AG, Jubilant Life Sciences Ltd., NutraScience Labs, DSM, BASF SE, Western Drugs Ltd., and Spectrum Chemical Mfg. Corp, and Fengchen Group Co., Ltd.

Which region will garner a significant value share by 2025?

The North American territory is projected to hold a revenue share of 27.8% over the forecast period.

At what CAGR is the global forecast to grow from 2025 to 2035?

The industry is projected to grow at a forecast CAGR of 5.2% from 2025 to 2035.

Recommendations

Nicotinic Acid Market
Estimated Industry Size (2025E) USD 362.4 million
Projected Industry Value (2035F) USD 601.7 million
Value-based CAGR (2025 to 2035) 5.2%
Nicotine Gums and Mints Market
Estimated Industry Size (2024E) USD 1,536.2 million
Projected Industry Value (2034F) USD 2,699.6 million
Value-based CAGR (2024 to 2034) 5.8%

Explore Functional Food Ingredients Insights

View Reports
Trusted By
Future Market Insights

Nicotinic Acid Market

Schedule a Call